CN
Drug Modalities
Technical Solutions
ESG
Newsroom
About Us
Contact Us
CN
CN
Home/Newsroom/Case Studies & Whitepapers

Case Studies & Whitepapers2026-05-22

Process Development Strategies for AOC Drugs Download

What is the mainstream conjugation process for antibodies and siRNA?
More
News
More

Case Studies & Whitepapers2026-06-30

Applications of Different Synthetic Strategies for Peptide Process Development

Applications of Different Peptide Synthesis Strategies in Process Development

Case Studies & Whitepapers2026-06-25

CMC Development Strategy for Oligonucleotides in AOCs

CMC

Become part of Porton's community to access personalized insights and resources.
Subscribe for the Newsletter
Porton requires your contact information to reach out to you about our products and services. You can unsubscribe from these communications at any time. For details on how to unsubscribe and our commitment to protecting your privacy, please review our Legal Disclaimer Terms and Porton Privacy.
US: (609) 860-1300
CN: (86) 23-8608-3200

ⓒ 2025 PORTON Legal Notices | Porton Privacy

This website provides information on products tailored for a diverse audience and may include product details or information that are not readily accessible or valid in your country. Please note that we do not accept any responsibility for accessing such information in a manner that may violate any legal processes, regulations, registrations, or usage guidelines in your country of origin.

Become part of Porton's community to access personalized insights and resources.
Submit
By clicking “Submit” you agree to our Legal Disclaimer terms and conditions and the Porton Privacy and Cookies Policy.

ⓒ 2025 PORTON Legal Notices | Porton Privacy

US: (609) 860-1300
CN: (86) 23-8608-3200

To access the complete page, kindly fill out this form.

First Name*
Last Name*
Business Email*
Company*
Department*
Job Title*
Continent*
By clicking “Submit" you agree to our Legal Disclaimer terms and conditions and the Porton Privacy and Cookies Policy.
Submit